enVVeno Medical
NVNO
16 hedge funds and large institutions have $8.52M invested in enVVeno Medical in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.
2,046% more capital invested
Capital invested by funds: $397K → $8.52M (+$8.12M)
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
129% more funds holding
Funds holding: 7 → 16 (+9)
0.25% more ownership
Funds ownership: 0.05% → 0.3% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.41M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$801K |
| 3 |
KC
Kepos Capital
New York
|
+$568K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$288K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$213K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$226K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
NVNO Hedge Fund Activity: Q1 2021 in Review
16 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2021, worth a combined $8.52M — up 2,046% from $397K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NVNO positions and 2 closed out — a net gain of 9 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $3.41M. The largest seller was Virtu Financial, exiting entirely with an estimated $226K sold.
- 16 institutional investors held enVVeno Medical (NVNO) as of Q1 2021, up from 7 in Q4 2020.
- Funds reported $8.52M of enVVeno Medical stock for Q1 2021, up 2,046% quarter-over-quarter.
- 11 funds opened new enVVeno Medical positions in Q1 2021 and 2 closed out, a net change of +9 holders.
- The largest enVVeno Medical buyer in Q1 2021 was AIGH Capital Management, an estimated $3.41M added.
- The largest enVVeno Medical seller in Q1 2021 was Virtu Financial, an estimated $226K sold.
Based on aggregated 13F filings for Q1 2021.